Crossed IPO listing price with volumes and retraced

1月28日

Windlas Biotech - CDMO. It manufactures medicines for big pharma companies.
Stock price moved above IPO listing price with volumes.
Price retraced and trying to move higher again.

My analysis it is doing similar to Mrs. Bector Foods price movement after it crossed IPO listing price.

If Pharma companies are doing Capex and the sector rotation happens then it should take Windlas higher.

Not a trading but thinking of it is a positional view. I will start investing in very less quantities hoping to make a decent return.

Check fundamentals before investing.

1月28日

註釋

I have a view of one or two years at max. Not for long term holding. There are lot of big CDMO companies in the market Syngene etc.
It might turn negative but I am investing only the amount that I am okay or comfortable to loose.

2月14日

註釋

I am still holding Windlas. Added 13 shares till now.
Windlas competitor Akum Drugs ( CDMO for Cipla, SUN, etc ) filed RHP with SEBI. Usually if an IPO is coming then the prices of the competitors also moves up. This is just an observation not a thumb rule. if market crashes IPOs will not come or IPOs will not perform/subscribe.

Keep a track on this. Not trading or investment call.

8月19日

手動結束交易

I sold Windlas at 700/-. Invested in Akum Drugs 70@725/-